Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI
Posted on: Tuesday, 3 March 2009, 07:00 CST
American Journal of Roentgenology Study Reveals Conclusive Findings in the Detection of Invasive Lobular Carcinoma
"The study is significant because ILC can often be difficult to detect mammographically and is often not palpable at clinical examination. BSGI offers improved detection of this form of breast cancer that impacts approximately 10 percent of new breast cancer patients every year," said Dr.
Brem and her colleagues conducted a retrospective multi-center study of women with biopsy-proven ILC. All patients had undergone mammography and BSGI, and the imaging findings were classified as positive or negative for invasive lobular carcinoma by experienced breast imagers. Ultrasound and MRI results, if performed, were included for analysis. The sensitivity of mammography, ultrasound, MRI and BSGI was determined for each modality and compared. Twenty-six women, ages 46 to 82 (mean age of 62.8), with 28 biopsy proven pure ILC, mean size of 22.3mm (2mm - 90mm), were included.
The study concludes that BSGI had the greatest sensitivity for the detection of ILC with a sensitivity of 93 percent. Mammography, ultrasound and MRI demonstrated sensitivities of 79 percent, 68 percent and 83 percent, respectively.
With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image. The Dilon 6800 Gamma Camera is a high-resolution, compact gamma camera, optimized to perform BSGI. The camera provides a manageable four to 16 images versus up to thousands of images with breast MRI.
"BSGI is a physiologic, rather than an anatomic, approach to breast cancer diagnosis. It is likely that the molecular imaging obtained with BSGI is the reason it has the greatest sensitivity for the detection of invasive lobular cancer," said Dr. Brem. "In our study, the sensitivity of BSGI for detecting ILC was greater than MRI. In fact it is known that MRI can be limited in the detection of ILC. In addition, the cost of BSGI is significantly less than a breast MRI."
The complete study can be found in The American Journal of Roentgenology, Invasive Lobular Carcinoma: Detection with Mammography, Sonography, MRI, and Breast-Specific Gamma Imaging, AJR: 192,
About Dilon Technologies
Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, compact field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including:
SOURCE Dilon Technologies Inc.
Source: PR Newswire
Related Articles
- Overall Risk of Malpractice Lawsuits in Breast Imaging Overestimated
- First Accredited CME Course on BSGI - the Molecular Breast Imaging Exam, Now Available to All Physicians
- New Data on Breast Imaging Using Cardiolite(R) to Be Presented at ASCO Breast Cancer Symposium
- Solis Women's Health Brings Molecular Breast Imaging to Dallas-Fort Worth Metroplex
- Frost and Sullivan Asia Pacific Market Insights Advances in Breast Imaging, Impact in Asia Pacific
- Imaging Diagnostic Systems Laser Breast Imaging Technology Presented at China's Leading Breast Disease Conference
- Molecular Breast Imaging Finds Tiny Tumors
- Elizabeth Jekot, M.D. Breast Imaging Center Offers Aurora Breast MRI to the Women of Richardson, Texas
- The Medipattern Corporation Begins Beta Testing of Breast Imaging Software, B-CAD'TM', in Industry-Leading Luminary Sites
- New Image of Earth, Seen Through Gamma-Ray Eyes
 |
 |
User Comments (0)
RSS Feeds